Tb fluvir 75 mg – Orris AI

Tb fluvir 75 mg

Reading File

Searching the Web

Fluvir 75 mg oseltamivir tablet uses dosage side effects

Finding Sources

Reading File

Here is a complete, textbook-based overview of Tab Fluvir 75 mg (Oseltamivir Phosphate 75 mg):

Tab Fluvir 75 mg - Oseltamivir Phosphate

Brand name: Fluvir (manufactured by Hetero Labs, India) Generic name: Oseltamivir phosphate 75 mg Drug class: Neuraminidase Inhibitor (Antiviral)

Mechanism of Action

Oseltamivir phosphate is an oral prodrug - it is rapidly absorbed and cleaved by esterases in the GI tract and liver to the active form, oseltamivir carboxylate, which is a transition-state analogue of sialic acid.

Influenza neuraminidase cleaves terminal sialic acid residues, which is essential for release of virus from infected cells and spread to other cells
Oseltamivir carboxylate binds the neuraminidase active site, causing a conformational change that inhibits its activity
This leads to viral aggregation at the cell surface and reduced spread within the respiratory tract
Active against Influenza A and B (including amantadine-resistant strains)
Goodman & Gilman's Pharmacological Basis of Therapeutics

Indications

Indication	Detail
Treatment of Influenza A & B	Must start within 48 hours of symptom onset for best effect
Prophylaxis of Influenza A & B	Post-exposure or seasonal prevention; for persons ≥1 year
H1N1 (Swine Flu)	Active; novel H1N1 remains susceptible
Severe/hospitalized influenza	Drug of choice for complications

Dosage

Indication	Dose	Duration
Treatment (adults & children >40 kg)	75 mg twice daily	5 days
Prophylaxis (adults)	75 mg once daily	At least 10 days (post-exposure)
Children (weight-based)	Weight-adjusted dosing	5 days

Take with or without food; taking with food reduces GI side effects
Dose must be adjusted in renal insufficiency (drug is renally excreted)
Harrison's Principles of Internal Medicine 22E (2025)

Pharmacokinetics (ADME)

Parameter	Detail
Absorption	Oral prodrug; rapidly absorbed and converted to active carboxylate
Food effect	Food does not reduce bioavailability; reduces GI intolerance
Distribution	Bronchoalveolar, middle ear, and sinus levels comparable to plasma
Excretion	Renally excreted via tubular secretion (anionic pathway)
Drug interaction	Probenecid doubles the plasma half-life

Side Effects

Common:

Nausea, vomiting, abdominal pain (most frequent)
Headache

Serious / Rare (monitor for):

Neuropsychiatric effects (confusion, hallucinations, abnormal behaviour, seizures) - reported especially in children and adolescents; unclear if drug-related or flu-related
Allergic/skin reactions (rash, Stevens-Johnson syndrome - rare)
Bronchospasm (uncommon)

Note: Families and caregivers should watch for unusual behavior in pediatric patients and contact a healthcare provider immediately if observed.

Contraindications & Precautions


Contraindicated	Known hypersensitivity to oseltamivir
Caution	Renal impairment (dose adjust), severe hepatic impairment
Caution	Chronic cardiac or respiratory disease
Pregnancy	Use only if benefit outweighs risk
Not a substitute	Does NOT replace annual flu vaccination

Resistance

Resistance can develop via mutations in viral neuraminidase or hemagglutinin
Resistance reported in ~15% of healthy children and ~1% of adults
More common in immunocompromised persons
Seasonal influenza A (H1N1) has historically shown high oseltamivir resistance; novel/pandemic H1N1 remains susceptible
Harrison's Principles of Internal Medicine 22E (2025), Goodman & Gilman's Pharmacological Basis of Therapeutics

Key Clinical Points

Most effective when started within 24-48 hours of symptom onset - shortens illness by ~1-2 days
Complete the full 5-day course even if you feel better
This is an antiviral, not an antibiotic - it will not treat bacterial infections or the common cold
The CDC flu treatment guidelines recommend oseltamivir as the drug of choice for hospitalized patients and those at high risk of complications

This is a shared conversation. Sign in to Orris to start your own chat.